Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy.

M. Drent, P. Wijnen, A. Bast

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

Medicinal agents, beside occupational and environmental agents, remain one of the most common causes for interstitial lung diseases (ILD). A major problem with ILD is the recognition of the causative agent. In some cases more or less characteristic features of presentation are described. Often, the connection between drug-use and the development of related inflammatory damage or idiosyncratic toxicities is hard to recognize and objectify. Cocaine, a xenobiotic and the most commonly used illicit drug, causes serious medical and social problems. An increasing incidence of lung toxicity related to cocaine or crack-use is being reported worldwide. However, the mechanism of the resulting lung injury is not fully understood. This review summarizes possible molecular mechanisms explaining intra-individual variability in cocaine response and lung toxicity. The importance of including pharmacogenomics in the work-up of patients with suspected drug-induced lung toxicity is highlighted.
Original languageEnglish
Pages (from-to)5607-5611
Number of pages5
JournalCurrent Medicinal Chemistry
Volume19
Issue number33
DOIs
Publication statusPublished - Nov 2012

Keywords

  • Cocaine
  • crack
  • CYP450
  • drug-induced toxicity
  • interstitial lung diseases
  • polymorphisms
  • oxidative stress
  • redox cycling
  • nitroxide radicals
  • cocaine metabolites
  • biotransformation
  • OBSTRUCTIVE PULMONARY-DISEASE
  • OXIDATIVE STRESS
  • BRONCHOALVEOLAR LAVAGE
  • CHEMICAL TOXICITY
  • CYTOCHROMES P450
  • METABOLISM
  • DRUGS
  • CRACK
  • VKORC1
  • ANTICOAGULATION

Cite this

@article{b7a376d4a9694576907221696f613518,
title = "Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy.",
abstract = "Medicinal agents, beside occupational and environmental agents, remain one of the most common causes for interstitial lung diseases (ILD). A major problem with ILD is the recognition of the causative agent. In some cases more or less characteristic features of presentation are described. Often, the connection between drug-use and the development of related inflammatory damage or idiosyncratic toxicities is hard to recognize and objectify. Cocaine, a xenobiotic and the most commonly used illicit drug, causes serious medical and social problems. An increasing incidence of lung toxicity related to cocaine or crack-use is being reported worldwide. However, the mechanism of the resulting lung injury is not fully understood. This review summarizes possible molecular mechanisms explaining intra-individual variability in cocaine response and lung toxicity. The importance of including pharmacogenomics in the work-up of patients with suspected drug-induced lung toxicity is highlighted.",
keywords = "Cocaine, crack, CYP450, drug-induced toxicity, interstitial lung diseases, polymorphisms, oxidative stress, redox cycling, nitroxide radicals, cocaine metabolites, biotransformation, OBSTRUCTIVE PULMONARY-DISEASE, OXIDATIVE STRESS, BRONCHOALVEOLAR LAVAGE, CHEMICAL TOXICITY, CYTOCHROMES P450, METABOLISM, DRUGS, CRACK, VKORC1, ANTICOAGULATION",
author = "M. Drent and P. Wijnen and A. Bast",
year = "2012",
month = "11",
doi = "10.2174/092986712803988901",
language = "English",
volume = "19",
pages = "5607--5611",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers",
number = "33",

}

Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy. / Drent, M.; Wijnen, P.; Bast, A.

In: Current Medicinal Chemistry, Vol. 19, No. 33, 11.2012, p. 5607-5611.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy.

AU - Drent, M.

AU - Wijnen, P.

AU - Bast, A.

PY - 2012/11

Y1 - 2012/11

N2 - Medicinal agents, beside occupational and environmental agents, remain one of the most common causes for interstitial lung diseases (ILD). A major problem with ILD is the recognition of the causative agent. In some cases more or less characteristic features of presentation are described. Often, the connection between drug-use and the development of related inflammatory damage or idiosyncratic toxicities is hard to recognize and objectify. Cocaine, a xenobiotic and the most commonly used illicit drug, causes serious medical and social problems. An increasing incidence of lung toxicity related to cocaine or crack-use is being reported worldwide. However, the mechanism of the resulting lung injury is not fully understood. This review summarizes possible molecular mechanisms explaining intra-individual variability in cocaine response and lung toxicity. The importance of including pharmacogenomics in the work-up of patients with suspected drug-induced lung toxicity is highlighted.

AB - Medicinal agents, beside occupational and environmental agents, remain one of the most common causes for interstitial lung diseases (ILD). A major problem with ILD is the recognition of the causative agent. In some cases more or less characteristic features of presentation are described. Often, the connection between drug-use and the development of related inflammatory damage or idiosyncratic toxicities is hard to recognize and objectify. Cocaine, a xenobiotic and the most commonly used illicit drug, causes serious medical and social problems. An increasing incidence of lung toxicity related to cocaine or crack-use is being reported worldwide. However, the mechanism of the resulting lung injury is not fully understood. This review summarizes possible molecular mechanisms explaining intra-individual variability in cocaine response and lung toxicity. The importance of including pharmacogenomics in the work-up of patients with suspected drug-induced lung toxicity is highlighted.

KW - Cocaine

KW - crack

KW - CYP450

KW - drug-induced toxicity

KW - interstitial lung diseases

KW - polymorphisms

KW - oxidative stress

KW - redox cycling

KW - nitroxide radicals

KW - cocaine metabolites

KW - biotransformation

KW - OBSTRUCTIVE PULMONARY-DISEASE

KW - OXIDATIVE STRESS

KW - BRONCHOALVEOLAR LAVAGE

KW - CHEMICAL TOXICITY

KW - CYTOCHROMES P450

KW - METABOLISM

KW - DRUGS

KW - CRACK

KW - VKORC1

KW - ANTICOAGULATION

U2 - 10.2174/092986712803988901

DO - 10.2174/092986712803988901

M3 - Article

VL - 19

SP - 5607

EP - 5611

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 33

ER -